Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leucine-rich repeat-containing protein 53 (LRRC53) is a member of the leucine-rich repeat (LRR) protein family, which are generally implicated in mediating protein–protein interactions. LRRC53 is a protein-coding gene in humans, but its precise biological function is currently unknown. It has been associated, at the genetic level, with diseases involving cardiac conduction and atrial conduction. The broader LRR family includes proteins important for innate immunity and neural development, although LRRC53's specific roles in such processes are undefined. No therapeutic drugs or targeted interactions have been described for LRRC53[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leucine-rich repeat-containing protein 53 (LRRC53).